Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Cancer Institute is soliciting applications to establish the Management and Data Coordination Unit as a primary scientific component of the Pancreatic Cancer Detection Consortium. This unit is tasked with supporting the early detection of pancreatic ductal adenocarcinoma and the characterization of precursor lesions to identify high risk patients. Key responsibilities include overseeing study design, protocol development, statistical analysis, data management, and providing organizational and logistics support, as well as assisting in the development of biorepositories. This initiative works in tandem with Research Units that focus on developing and testing molecular and imaging biomarkers for early detection and intervention. Managed by the National Institutes of Health under the Department of Health and Human Services, this forecast is categorized under NAICS code 541715 and specifically prohibits clinical trials.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is soliciting applications for the establishment of the Management and Data Coordination Unit (MDCU), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC). The PCDC will continue to address one of the four research priorities identified in the National Cancer Institute's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma and conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify those patients who are at high risk of progression to cancer. The PCDC-MDCU will provide support toward collaborative efforts such as: study design, protocol development, statistical analysis, coordination and data management. Other PCDC-MDCU activities include: coordination and support toward biorepository building; and organizational and logistics support for PCDC activities.
The other scientific component of the PCDC will be the Research Units. The PCDC-RUs will conduct research for the development and testing of new molecular and imaging biomarkers for early detection of PDAC and/or for identifying those patients at high risk of PDAC (because of genetic factors and/or family history or presence of precursor lesions) who could be candidates for early intervention.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
